Fitch Upgrades Hikma Pharmaceuticals Plc’s Long-term Issuer Default Rating To ‘BBB’, Outlook Stable
By Ron Chen, Bureau Chief, Asia Hikma Pharmaceuticals Plc has announced that Fitch has upgraded its long-term issuer default rating and the...
archivehikma pharmaceuticals plc
